This case study describes a collaborative approach to reducing inappropriate postoperative topical antibiotic use, supporting the launch of the Cataract Clinical Care Standard.

This case study describes a nurse-led postoperative cataract clinic as an example of innovation in care, supporting the launch of the Cataract Clinical Care Standard.

This case study describes a nurse-led assessment clinic for routine cataract, to support the launch of the Cataract Clinical Care Standard.

This case study describes a referral and triage pathway for cataract care, consistent with the Cataract Clinical Care Standard.

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU), in Australia.

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU), in Australia.

The focus of Chapter 5 is CARAlert, the National Alert System for Critical Antimicrobial Resistances in Australia; this resource providing figures and tables for use in presentations and other documents, to allow ease of access to data at the local and jurisdiction levels. 

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU) in Australia. The focus of Chapter 4 is AMR in Australia, with this resource providing figures and tables for use in presentations and other documents, to allow ease of access to data at the local level, and for all jurisdictions. 

AURA 2021 is the fourth in a series of national reports on the critical issues of antimicrobial resistance (AMR), and the use of antimicrobials (AU), in Australia.

The focus of Chapter 3 is antimicrobial use and the appropriateness of use in Australia; this resource provides figures and tables for use in presentations and other documents, to allow ease of access to data at the local level, and for all jurisdictions. 

This brochure provides information for consumers regarding infections for which antibiotics may not be appropriate, and the role of antibiotics in the development of antimicrobial resistance.

The Consumer Summary provides an overview of the key findings and messages of AURA 2021 for consumers.